Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY24.00 CNY
Change Today -0.61 / -2.48%
Volume 9.3M
601607 On Other Exchanges
Symbol
Exchange
Shanghai
Berlin
OTC US
OTC US
Hong Kong
As of 10:13 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
CNY24.56
Previous Close
CNY24.61
Day High
CNY24.60
Day Low
CNY23.86
52 Week High
04/27/15 - CNY28.51
52 Week Low
05/19/14 - CNY11.65
Market Cap
60.8B
Average Volume 10 Days
41.1M
EPS TTM
CNY1.02
Shares Outstanding
1.9B
EX-Date
05/26/14
P/E TM
23.6x
Dividend
CNY0.26
Dividend Yield
1.06%
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches and develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. The company operates through Production, Distribution, Retail, and Others segments. It offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, antineoplastic, musculo-skeletal, respiratory, and genito-urinary systems, as well as offers sex hormones and products for blood and blood-forming organs. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It is also involved in the distribution of vaccines and high-end consumables; wholesale of active pharmaceutical ingredients; and provision of distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company operates a network of retail pharmacy stores; manages assets; manufactures and trades medicines and medical equipment; and rents properties. It has approximately 1,895 chain retail pharmacies under its brand family, including 1,193 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

39,891 Employees
Last Reported Date: 03/26/15
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY1.6M
Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. to Report Q1, 2015 Results on Apr 29, 2015

Shanghai Pharmaceuticals Holding Co., Ltd. announced that they will report Q1, 2015 results on Apr 29, 2015

Shanghai Pharmaceuticals Holding Co., Ltd. Reports Unaudited Consolidated and Parent Earnings Results for the First Quarter Ended March 31, 2015; Reports Consolidated and Parent Asset Impairment Loss for the First Quarter Ended March 31, 2015

Shanghai Pharmaceuticals Holding Co., Ltd. reported unaudited consolidated and parent earnings results for the first quarter ended March 31, 2015. For the quarter, the consolidated company reported basic and diluted earnings per share of RMB 0.2727 against RMB 0.2180 a year ago. Weighted average return on net assets was 2.60%. Profit attributable to shareholders of RMB 733 million in the first quarter by the end of March, rising 25.08% from a year earlier. The company harvested operating revenue of RMB 3.077 billion from drug production, climbing 9.24%. Total Revenue was RMB 25,125,001,197.57 against RMB 21,274,115,894.43 a year ago. Operating profit was RMB 997,498,234.96 against RMB 850,934,969.54 a year ago. Total profit was RMB 1,024,423,410.80 against RMB 855,432,822.86 a year ago. For the quarter, the parent company reported revenue was RMB 18,577,910.40 against RMB 819,918.91 a year ago. Operating profit was RMB 277,168,750.43 against RMB 101,110,742.59 a year ago. Total profit was RMB 281,132,927.16 against RMB 100,837,446.59 a year ago. Net profit was RMB 281,132,927.16 against RMB 100,837,446.59 a year ago. Net cash flows used in operating activities was RMB 142,084,298.04 against RMB 564,590,746.82 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 403,744,331.39 against RMB 178,967,422.44 a year ago. For the quarter, the consolidated company reported asset impairment loss of RMB 54,016,932.17 against RMB 11,366,524.26 a year ago. For the quarter, the parent company reported Asset impairment loss was RMB 3,854,140.00 against nil a year ago.

Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Dividend for 2014

Shanghai Pharmaceuticals Holding Co., Ltd. announced that at the AGM to be held on May 29, 2015, the company will consider the profit distribution plan for 2014 as follows: it is proposed that, based on the total share capital of 2,688,910,538 shares as at December 31, 2014, a cash dividend of RMB 2.9 (tax inclusive) will be paid to all shareholders for every ten shares, totaling RMB 779,784,056.02, accounting for 30.09% of the consolidated profit attributable to owners of the company for 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY24.00 CNY -0.61

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY68.36 CNY +1.11
Jointown Pharmaceutical Group Co Ltd CNY24.19 CNY -1.09
Nanjing Pharmaceutical Co Ltd CNY12.64 CNY -0.54
Wanjia Group Holdings Ltd $0.62 HKD -0.03
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 24.9x
Price/Sales 0.7x
Price/Book 2.4x
Price/Cash Flow 17.8x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.